These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25830365)

  • 1. Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteins.
    Peyret H; Gehin A; Thuenemann EC; Blond D; El Turabi A; Beales L; Clarke D; Gilbert RJ; Fry EE; Stuart DI; Holmes K; Stonehouse NJ; Whelan M; Rosenberg W; Lomonossoff GP; Rowlands DJ
    PLoS One; 2015; 10(4):e0120751. PubMed ID: 25830365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
    Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
    Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
    Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
    J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.
    Kratz PA; Böttcher B; Nassal M
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1915-20. PubMed ID: 10051569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple optimizations of recombinant plasmid for improving expression of Hepatitis B core antigen in Escherichia coli.
    Zhang Y; Guo M; Zhang X; Zhang N; Zhu P; Wang H
    Protein Expr Purif; 2022 Oct; 198():106127. PubMed ID: 35660658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted.
    Brown AL; Francis MJ; Hastings GZ; Parry NR; Barnett PV; Rowlands DJ; Clarke BE
    Vaccine; 1991 Aug; 9(8):595-601. PubMed ID: 1722937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
    Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
    Ramirez A; Morris S; Maucourant S; D'Ascanio I; Crescente V; Lu IN; Farinelle S; Muller CP; Whelan M; Rosenberg W
    Vaccine; 2018 Feb; 36(6):873-880. PubMed ID: 29306508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions.
    Kazaks A; Lachmann S; Koletzki D; Petrovskis I; Dislers A; Ose V; Skrastina D; Gelderblom HR; Lundkvist A; Meisel H; Borisova G; Krüger DH; Pumpens P; Ulrich R
    Intervirology; 2002; 45(4-6):340-9. PubMed ID: 12602354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal core protein cleavage leaves the hepatitis B virus capsid intact and enhances its capacity for surface display of heterologous whole chain proteins.
    Walker A; Skamel C; Vorreiter J; Nassal M
    J Biol Chem; 2008 Nov; 283(48):33508-15. PubMed ID: 18826949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.
    Schödel F; Peterson D; Hughes J; Milich DR
    Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically engineered fusion of allergen and viral-like particle induces a more effective allergen-specific immune response than a combination of them.
    Sani MZ; Bargahi A; Momenzadeh N; Dehghani P; Moghadam MV; Maleki SJ; Nabipour I; Shirkani A; Akhtari J; Hesamizadeh K; Heidari S; Omrani F; Akbarzadeh S; Mohammadi M
    Appl Microbiol Biotechnol; 2021 Jan; 105(1):77-91. PubMed ID: 33215260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a human cytomegalovirus gp58 antigenic domain fused to the hepatitis B virus nucleocapsid protein.
    Tarar MR; Emery VC; Harrison TJ
    FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):183-92. PubMed ID: 9116635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency.
    Ravin NV; Blokhina EA; Kuprianov VV; Stepanova LA; Shaldjan AA; Kovaleva AA; Tsybalova LM; Skryabin KG
    Vaccine; 2015 Jun; 33(29):3392-7. PubMed ID: 25937448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBcAg produced in transgenic tobacco triggers Th1 and Th2 response when intramuscularly delivered.
    Pyrski M; Rugowska A; Wierzbiński KR; Kasprzyk A; Bogusiewicz M; Bociąg P; Samardakiewicz S; Czyż M; Kurpisz M; Pniewski T
    Vaccine; 2017 Oct; 35(42):5714-5721. PubMed ID: 28917537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2.
    Arora U; Tyagi P; Swaminathan S; Khanna N
    J Nanobiotechnology; 2012 Jul; 10():30. PubMed ID: 22794664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, purification, crystallization and preliminary crystallographic analysis of hepatitis B virus core protein dimerized via a peptide linker containing an EGFP insertion.
    Kikuchi M; Iwabuchi S; Kikkou T; Noguchi K; Odaka M; Yohda M; Kawata M; Sato C; Matsumoto O
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Aug; 69(Pt 8):942-5. PubMed ID: 23908049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of chimeric hepatitis B core particles into liver cells.
    Lee KW; Tey BT; Ho KL; Tan WS
    J Appl Microbiol; 2012 Jan; 112(1):119-31. PubMed ID: 21992228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.